New drug CIT-013 tested for safety in small human trial
Knowledge-focused
Not yet recruiting
This phase 1 trial will test the safety and tolerability of a drug called CIT-013 in 10 healthy adults. Participants receive either CIT-013 or a placebo by injection under the skin. The study is double-blind, meaning neither participants nor researchers know who gets the real dru…
Phase: PHASE1 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC